Skip to search formSkip to main contentSkip to account menu

Truvada

National Institutes of Health

Related topics

Related topics

4 relations

Broader (3)

Tenofovir disoproxil fumarateemtricitabinetenofovir disoproxil
emtricitabine 200 MG / Tenofovir disoproxil fumarate 300 MG Oral Tablet [Truvada]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Les patients vivants avec le VIH (PVVIH) acceptent-ils les génériques dans la vraie vie ?
Review
2015
Review
2015
Survey of PEPSE provision: lessons to be learnt
Postexposure prophylaxis following sexual exposure (PEPSE) to HIV is increasingly being offered and accessed by patients. A… 
2014
2014
Safety analysis of raltegravir/truvada regimen in HIV/HCV co-infected patients without switchback after HCV treatment
Due to drug‐drug interactions of HIV‐ and HCV‐specific antivirals when initiating an HCV‐therapy, the antiretroviral therapy (ART… 
2014
2014
First Line Therapy in 2014
The choice of antiretroviral therapy for those naive to therapy is vast, with over 30 drugs available for the treatment of HIV… 
2013
2013
The Incidence of Diabetes Mellitus among Human Immunodeficiency Virus ( HIV ) Positive Patients on Therapy in Nnewi
Diabetes Mellitus (DM) is a common disorder affecting individuals of all ages. Similar to general population, diabetes mellitus… 
2012
2012
Hematological and Metabolic Toxicities of Current Antiretroviral Regimens in Ahmadu Bello University Teaching Hospital Shika Zaria, Northern Nigeria
The introduction of the highly active antiretroviral therapy (HAART) in 1996 has drastically reduced the morbidity and mortality… 
2011
2011
Protection against Rectal Transmission of an Emtricitabine-Resistant Simian/Human Immunodeficiency Virus SHIV162p3M184V Mutant by Intermittent Prophylaxis with Truvada
ABSTRACT Daily preexposure prophylaxis (PrEP) with Truvada (emtricitabine [FTC] and tenofovir disoproxil fumarate [TDF]) is a… 
2009
2009
Effectiveness and safety of simplification from tenofovir-lamivudine (TDF-3TC) to tenofovir-emtricitabine (TDF-FTC) co-formulation (Truvada®) in virologically suppressed HIV-infected patients on…
The objective was to evaluate the effectiveness and safety of simplification from tenofovir-lamivudine (TDF-3TC) to Truvada® (TVD… 
2008
2008
The TOKEN study: safety and efficacy of Truvada or Kivexa in combination with efavirenz in treatment-naïve predominantly black African HIV patients
of results Of 139 patients, 81 were on Truvada and 58 on Kivexa. Most were black African (69%), mean age 38.1 (+/8.1) years and… 
2007
2007
A truvada hypersensitivity reaction simulating abacavir hypersensitivity.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)